Literature DB >> 23335532

Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with advanced non-small cell lung cancer: single center experience.

A Inal1, M Kucukoner, M A Kaplan, Z Urakci, A Karakus, H Komek, Z Dostbil, A Isikdogan.   

Abstract

PURPOSE: The purpose of this retrospective single-center study was to evaluate the prognostic implication on overall survival (OS) of the F-18 FDG PET scan in locally advanced or metastatic non small cell lung cancer (NSCLC) patients.
METHODS: We retrospectively reviewed 120 locally advanced or metastatic NSCLC patients (December 2004-November 2011) treated/followed at the Dicle University, School of Medicine, Department of Medical Oncology. SUVmax and other potential prognostic variables (n=18) were chosen for analysis. Univariate and multivariate analyses were conducted to identify prognostic factors for OS.
RESULTS: Among 18 variables of univariate analysis, 6 were identified to bear prognostic significance: sex (p=0.01), performance status (PS) (p =0.03), stage (p=0.04), bone metastases (p=0.002), serum albumin (p=0.01) and blood glucose level (p=0.03). Multivariate analysis showed that PS, bone metastases and serum albumin level were independent prognostic factors for OS (p=0.01, p=0.004, p=0.003, respectively).
CONCLUSION: PS, serum albumin levels and bone metastases were independent prognostic factors, while FDG uptake of the primary lesion was not associated with prognosis of OS in locally advanced or metastatic NSCLC patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23335532

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  3 in total

1.  Identifying 18F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module.

Authors:  Jin Li; Yixin Liu; Wenlei Dong; Yang Zhou; Jingquan Wu; Kuan Luan; Lishuang Qi
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  Value of 18F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations.

Authors:  Bin Yang; Hengshan Ji; Jing Zhong; Lu Ma; Jian Zhong; Hao Dong; Changsheng Zhou; Shaofeng Duan; Chaohui Zhu; Jiahe Tian; Longjiang Zhang; Feng Wang; Hong Zhu; Guangming Lu
Journal:  Front Oncol       Date:  2020-11-11       Impact factor: 6.244

3.  Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer.

Authors:  Xuan Canh Nguyen; Van Khoi Nguyen; Minh Thong Tran; Simone Maurea; Marco Salvatore
Journal:  World J Nucl Med       Date:  2014-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.